NO20054243L - Kombinasjon av desoksypeganin og mecamylamin for behandling av alkoholmisbruk. ion eller et salt derav (forkortelse: NTBC). kseptabelt salt saerlig caspofunginacetat - Google Patents

Kombinasjon av desoksypeganin og mecamylamin for behandling av alkoholmisbruk. ion eller et salt derav (forkortelse: NTBC). kseptabelt salt saerlig caspofunginacetat

Info

Publication number
NO20054243L
NO20054243L NO20054243A NO20054243A NO20054243L NO 20054243 L NO20054243 L NO 20054243L NO 20054243 A NO20054243 A NO 20054243A NO 20054243 A NO20054243 A NO 20054243A NO 20054243 L NO20054243 L NO 20054243L
Authority
NO
Norway
Prior art keywords
deoxypeganine
mecamylamine
treatment
ntbc
abbreviation
Prior art date
Application number
NO20054243A
Other languages
English (en)
Inventor
Klaus Opitz
Joachim Moormann
Hilke Winterhoff
Original Assignee
Hf Arzneimittelforsch Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hf Arzneimittelforsch Gmbh filed Critical Hf Arzneimittelforsch Gmbh
Publication of NO20054243L publication Critical patent/NO20054243L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Addiction (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cephalosporin Compounds (AREA)

Abstract

En aktiv substans kombinasjon, består av deoksypeganin eller et av dens farmasøytisk akseptable derivater og mecamylamin eller et av dens farmasøytisk akseptable derivater og tjener til å fremstille et medikament for behandling av alkoholmisbruk og/eller alkoholavhengighet.
NO20054243A 2003-04-25 2005-09-13 Kombinasjon av desoksypeganin og mecamylamin for behandling av alkoholmisbruk. ion eller et salt derav (forkortelse: NTBC). kseptabelt salt saerlig caspofunginacetat NO20054243L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10318714A DE10318714B4 (de) 2003-04-25 2003-04-25 Wirkstoff-Kombinationen und Therapien zur Bekämpfung des Alkoholmissbrauches
PCT/EP2004/004033 WO2004096200A1 (de) 2003-04-25 2004-04-16 Kombination aus desoxypeganin und mecamylamin zur behandlung des alkoholmissbrauches

Publications (1)

Publication Number Publication Date
NO20054243L true NO20054243L (no) 2005-09-13

Family

ID=33304936

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20054243A NO20054243L (no) 2003-04-25 2005-09-13 Kombinasjon av desoksypeganin og mecamylamin for behandling av alkoholmisbruk. ion eller et salt derav (forkortelse: NTBC). kseptabelt salt saerlig caspofunginacetat

Country Status (18)

Country Link
US (1) US20060199866A1 (no)
EP (1) EP1617831A1 (no)
JP (1) JP2006524647A (no)
KR (1) KR20060006946A (no)
CN (1) CN1771029A (no)
AR (1) AR044067A1 (no)
AU (1) AU2004233564A1 (no)
BR (1) BRPI0410507A (no)
CA (1) CA2523331A1 (no)
CL (1) CL2004000881A1 (no)
DE (1) DE10318714B4 (no)
EA (1) EA200501514A1 (no)
MX (1) MXPA05011249A (no)
MY (1) MY136408A (no)
NO (1) NO20054243L (no)
TW (1) TW200427452A (no)
WO (1) WO2004096200A1 (no)
ZA (1) ZA200507213B (no)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008045641A2 (en) * 2006-10-10 2008-04-17 The University Of Chicago Composition s comprising a benzodiazepine, an alcohol aversive agent and an abuse aversive agent
CN108498493A (zh) * 2017-02-27 2018-09-07 中国人民解放军第二军医大学 美加明防治晕动症或眩晕症的医药用途

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3797494A (en) * 1969-04-01 1974-03-19 Alza Corp Bandage for the administration of drug by controlled metering through microporous materials
US3996934A (en) * 1971-08-09 1976-12-14 Alza Corporation Medical bandage
US3742951A (en) * 1971-08-09 1973-07-03 Alza Corp Bandage for controlled release of vasodilators
US4031894A (en) * 1975-12-08 1977-06-28 Alza Corporation Bandage for transdermally administering scopolamine to prevent nausea
DE3315272C2 (de) * 1983-04-27 1986-03-27 Lohmann Gmbh & Co Kg, 5450 Neuwied Pharmazeutisches Produkt und Verfahren zu seiner Herstellung
US5316759A (en) * 1986-03-17 1994-05-31 Robert J. Schaap Agonist-antagonist combination to reduce the use of nicotine and other drugs
DE3843239C1 (no) * 1988-12-22 1990-02-22 Lohmann Therapie Syst Lts
WO1999017803A1 (en) * 1997-10-03 1999-04-15 Cary Medical Corporation Compositon for the treatment of nicotine addiction containing a nicotine receptor antagonist and an anti-depressant or anti-anxiety drug
CA2393442A1 (en) * 1998-12-16 2000-06-22 University Of South Florida Exo-r-mecamylamine formulation and use in treatment
DE19906974C2 (de) * 1999-02-19 2003-10-09 Lohmann Therapie Syst Lts Verwendung von Desoxypeganin zur Behandlung des Alkoholismus
DE10129265A1 (de) * 2001-06-18 2003-01-02 Hf Arzneimittelforsch Gmbh Wirkstoff-Kombination zur medikamentösen Sucht- oder Rauschmitteltherapie

Also Published As

Publication number Publication date
DE10318714A1 (de) 2004-11-18
WO2004096200A1 (de) 2004-11-11
US20060199866A1 (en) 2006-09-07
MY136408A (en) 2008-09-30
KR20060006946A (ko) 2006-01-20
TW200427452A (en) 2004-12-16
CN1771029A (zh) 2006-05-10
JP2006524647A (ja) 2006-11-02
EP1617831A1 (de) 2006-01-25
DE10318714B4 (de) 2006-03-23
EA200501514A1 (ru) 2006-04-28
MXPA05011249A (es) 2005-12-14
CA2523331A1 (en) 2004-11-11
AU2004233564A1 (en) 2004-11-11
CL2004000881A1 (es) 2005-01-21
ZA200507213B (en) 2006-05-31
BRPI0410507A (pt) 2006-06-20
AR044067A1 (es) 2005-08-24

Similar Documents

Publication Publication Date Title
NO20051987L (no) Behandling av soppinfeksjoner.
NO340679B1 (no) Pyridazinonderivativer, farmasøytiske preparater omfattende slike og slike forbindelser og preparater for anvendelse i terapeutisk aktive substanser til behandling og forebygging av sykdommer
WO2008040534A3 (en) Non-mucoadhesive film dosage forms
BRPI0413427A (pt) derivados de piridilpirrol ativos como inibidores da cinase
ATE470443T1 (de) Indol-1-yl-essigsäurederivate
NO20055631L (no) Doseringsform inneholdende pantoprazol som aktiv ingrediens
NO20080220L (no) Formuleringer med hoy medikament belastning og doseringsformer
CU23367A3 (es) Formulación de moxifloxacino con sal común
NO20071354L (no) anvendelse av samme Butylftalid selvemulsifiserene medikamentavgivelsessystem, samt fremgangsmater for fremstilling og anvendelse av samme.
NO20044487L (no) Kombinasjon av organiske forbindelser
CY1107819T1 (el) Φαρμακευτικη διαμορφωση της ολανζαπινης
UA102254C2 (ru) Жидкий состав для деферипрона с приятным вкусом
CY1117174T1 (el) ΧΡΗΣΗ 24-norUDCA ΓΙΑ ΤΗΝ ΑΓΩΓΗ ΧΟΛΟΣΤΑΤΙΚΩΝ ΝΟΣΗΜΑΤΩΝ ΤΟΥ ΗΠΑΤΟΣ
WO2004105485A3 (en) Inducible release vehicles
EA200601901A1 (ru) Композиции, содержащие иммуномодулирующие соединения для лечения и управления течением миелодиспластических синдромов и способы с их использованием
WO2008128191A3 (en) Oral cephalotaxine dosage forms
DE502004010514D1 (de) Pharmazeutische Zusammensetzung zur Behandlung von Rhinitiden
WO2007009691A3 (en) Combination of substituted pyrazolines and anti -addictive agent
PT1414467E (pt) Tratamento topico da mastalgia
NO20073575L (no) Farmasoytiske sammensetninger for behandling av cellulitt
NO20054243L (no) Kombinasjon av desoksypeganin og mecamylamin for behandling av alkoholmisbruk. ion eller et salt derav (forkortelse: NTBC). kseptabelt salt saerlig caspofunginacetat
AR036321A1 (es) Metodo y formulacion farmaceutica para el tratamiento de la discinesia de aparicion tardia.
WO2004071402A3 (en) STABLE PHARMACEUTICAL DOSAGE FORM COMPRISING HMG-CoA REDUCTASE INHIBITOR
NO20054320L (no) Terapeutisk middel mot hemoroidesykdom
NO20064196L (no) Utvortes preparat for behandling av smertefulle hudskader

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application